Lower open as housing starts disappoint

March housing starts rose less than expected to weigh down the markets to a lower open with Dow losing 33 points to 18,079. Nasdaq lost 10 points to 5,000.

On the upside

The Food and Drug Administration granted Fast Track designation to MedicNova's (Nasdaq: MNOV) MN-001 to treat nonalcoholic steatohepatitis with fibrosis.

Rosetta Genomics (Nasdaq: ROSG) received a patent allowance for a method of identifying a tissue of origin of a cancer sample.

First quarter earnings fell for Netflix (Nasdaq: NFLX) due to the strong dollar but the results were better than expected and the video streaming service added more subscribers than anticipated.

On the downside

SanDisk (Nasdaq: SNDK) disappointed with lower first quarter earnings that missed analyst expectations as revenue fell prompting a downgrade.

Pernix Therapeutics (Nasdaq: PTX) commenced a private offering of $120 million in convertible senior notes.

Pacira (Nasdaq: PCRX) received a subpoena from the Justice Department for documents related to the marketing and promotion practices of Exparel.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 lost 4 points to 2101. Bitcoin added $5 to $225.

About this Entry

This page contains a single entry by published on April 16, 2015 6:42 AM.

Soaring crude oil prices lift markets was the previous entry in this blog.

Markets flat at midday is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12